Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer
The Journal of Rural Health · 2026
DOI: 10.1111/jrh.70148 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Rural Health, 2026. Verfasst von Zhaoli Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, Texas, USA. Hauptthemen laut MEDLINE: Hospitals, Rural, Health Facility Closure. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Cancer Prevention and Research Institute of Texas, NIH/NCI.
Abstract (Originalsprache)
Purpose
To examine the impact of rural hospital closures on mortality among patients with colorectal, lung, breast, and prostate cancer.
Methods
This retrospective observational cohort study uses SEER‐Medicare linkage data from 2000–2020 to evaluate all‐cause and cancer‐specific mortality among Medicare beneficiaries diagnosed with colorectal, lung, breast, or prostate cancer. The closure group included patients living in counties that experienced rural hospital closures; the control group consisted of patients from propensity score‐matched rural counties with sustained hospital access. The primary outcomes were all‐cause and cancer‐specific mortality among patients with colorectal, lung, breast, and prostate cancer. Analyses compared outcomes before and after rural hospital closures and between rural counties with and without closures.
Findings
A total of 33,716 cancer patients were included. Cox proportional hazards analyses revealed significantly higher all‐cause mortality among colorectal cancer patients living in counties that experienced rural hospital closures (HR = 1.139, 95% CI: 1.030–1.259), but no significant difference was observed among those living in control counties, after adjusting for covariates. For lung cancer patients, significantly lower cancer‐specific mortality was observed in control counties during the post‐closure period (HR = 0.906, 95% CI: 0.834–0.983), with no significant difference in the closure group. No significant effects were found for breast or prostate cancer patients.
Conclusions
Rural hospital closures are associated with worse survival outcomes for colorectal and lung cancer patients but not for breast or prostate cancer patients. Targeted policy interventions are needed to mitigate the adverse effects of hospital closures on cancer care in rural communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, Texas, USA.
- Department of Biostatistics & Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, Texas, USA.
- Departments of Breast Medical Oncology and Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.
ORCID-Profile: Zhaoli Liu
Förderung
- NCI NIH HHS
- Cancer Prevention and Research Institute of Texas
- NIH/NCI
Zitieren
APA
Liu, Z., Gao, D., Martin, T., Winegar, R., Giordano, S. H., & Kuo, Y. F. (2026). Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer. The Journal of Rural Health. https://doi.org/10.1111/jrh.70148
Vancouver
Liu Z, Gao D, Martin T, Winegar R, Giordano SH, Kuo YF. Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer. The Journal of Rural Health. 2026. doi:10.1111/jrh.70148
BibTeX
@article{Liu2026,
author = {Liu, Zhaoli and Gao, Daoqi and Martin, Tara and Winegar, Rhonda and Giordano, Sharon H and Kuo, Yong-Fang},
title = {Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer},
journal = {The Journal of Rural Health},
year = {2026},
doi = {10.1111/jrh.70148}
}
EUVIMED